QY101
/ E-nitiate Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
December 14, 2023
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY101 Ointment in Patients With Plaque Psoriasis
(clinicaltrials.gov)
- P2 | N=160 | Recruiting | Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
New P2 trial • Dermatology • Immunology • Psoriasis
September 25, 2023
A First-in-Human Study of QY101 Ointment in Adult Subjects
(clinicaltrials.gov)
- P1 | N=77 | Completed | Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | Recruiting ➔ Completed
Trial completion
February 16, 2023
A First-in-Human Study of QY101 Ointment in Adult Subjects
(clinicaltrials.gov)
- P1 | N=76 | Recruiting | Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
June 23, 2022
A First-in-Human Study of QY101 Ointment in Adult Subjects
(clinicaltrials.gov)
- P1 | N=76 | Not yet recruiting | Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
New P1 trial
1 to 4
Of
4
Go to page
1